Topics

Illumina forms 15-year cancer sequencing deal with Roche

12:12 EST 15 Jan 2020 | MedCity News

genomics

Separately, the next-generation sequencing manufacturer will also work with Genomics England to sequence up to 300,000 people over the next five years.

Original Article: Illumina forms 15-year cancer sequencing deal with Roche

NEXT ARTICLE

More From BioPortfolio on "Illumina forms 15-year cancer sequencing deal with Roche"

Quick Search

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...